Literature DB >> 3624453

Effect of inoculum size on results of macrotube broth dilution susceptibility tests with Branhamella catarrhalis.

G V Doern, T Tubert.   

Abstract

The effect of inoculum size on the results of macrotube broth dilution MICs was assessed with 15 strains of Branhamella catarrhalis versus 22 antimicrobial agents. The study isolates included five beta-lactamase-negative strains, five strains that produced beta-lactamase and for which ampicillin MICs were high, and five beta-lactamase-producing strains for which ampicillin MICs were low. An inoculum effect was observed only with strains in the last group when tested versus the following antimicrobial agents: penicillin G, ampicillin, cephalothin, cefamandole, cefuroxime, and cefaclor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3624453      PMCID: PMC269279          DOI: 10.1128/jcm.25.8.1576-1578.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

Review 1.  Branhamella catarrhalis--an emerging human pathogen.

Authors:  G V Doern
Journal:  Diagn Microbiol Infect Dis       Date:  1986-03       Impact factor: 2.803

2.  In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.

Authors:  S Alvarez; M Jones; S Holtsclaw-Berk; J Guarderas; S L Berk
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

3.  Branhamella catarrhalis.

Authors: 
Journal:  Lancet       Date:  1982-05-29       Impact factor: 79.321

4.  Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid.

Authors:  G Ninane; J Joly; M Kraytman; P Piot
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

5.  Branhamella (Neisseria) catarrhalis systemic disease in humans. Case reports and review of the literature.

Authors:  G V Doern; M J Miller; R E Winn
Journal:  Arch Intern Med       Date:  1981-11

6.  Branhamella (Neisseria) catarrhalis--a lower respiratory tract pathogen?

Authors:  M A Johnson; W L Drew; M Roberts
Journal:  J Clin Microbiol       Date:  1981-06       Impact factor: 5.948

7.  Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections.

Authors:  N J Slevin; J Aitken; P E Thornley
Journal:  Lancet       Date:  1984-04-07       Impact factor: 79.321

8.  In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains.

Authors:  K G Sweeney; A Verghese; C A Needham
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

9.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

10.  Branhamella catarrhalis pneumonia.

Authors:  M H Louie; E L Gabay; G E Mathisen; S M Finegold
Journal:  West J Med       Date:  1983-01
View more
  5 in total

Review 1.  Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.

Authors:  G V Doern; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

2.  In vitro activities of 39 antimicrobial agents for Branhamella catarrhalis and comparison of results with different quantitative susceptibility test methods.

Authors:  G V Doern; T A Tubert
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

Review 3.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

Review 4.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

Review 5.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.